Journal of Agricultural and Food Chemistry· 2026Q1
Ameliorative Effects of Casein Peptides on Constipation-Predominant Irritable Bowel Syndrome: Involvement of the GC-C/cGMP Signaling Pathway
- 0citations
- Q1SCImago
- 2026year
Short summary
Casein hydrolyzate significantly improved constipation symptoms, reduced visceral hypersensitivity, and enhanced intestinal barrier integrity in IBS-C mice, mediated by increased colonic cGMP levels, suggesting GC-C pathway involvement.
AI-generated from the title and abstract; the full text is not read.
Key points
- Casein hydrolyzate reduced constipation symptoms and visceral hypersensitivity in IBS-C mice.
- Intestinal barrier integrity and inflammatory responses were improved by casein hydrolyzate.
- Colonic cGMP levels increased significantly with casein hydrolyzate, suggesting GC-C pathway activation.
- The peptide PFPGPIPN showed high GC-C agonistic activity and ameliorated IBS-C symptoms in vivo.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract This study investigated the effects of casein peptides on constipation-predominant irritable bowel syndrome (IBS-C) in mice. Results revealed that oral administration of casein hydrolyzate significantly attenuated constipation symptoms, reduced visceral hypersensitivity, improved intestinal barrier integrity, suppressed inflammatory responses, and restored serum neurotransmitter balance in IBS-C mice. Casein hydrolyzate did not alter guanylyl cyclase C (GC-C) mRNA levels but significantly increased cyclic guanosine-3‘,5′-monophosphate (cGMP) levels in the colon of IBS-C mice, suggesting the possible involvement of the GC-C/cGMP signaling pathway in the above effects. Additionally, nine casein peptides with potential GC-C agonistic activity were identified through an integrated in silico screening and ex vivo functional evaluation, among which PFPGPIPN showed the highest activity. Moreover, in vivo experiments confirmed that PFPGPIPN significantly ameliorated IBS-C symptoms and elevated colonic cGMP levels in mice. These findings highlight the potential of casein peptides as bioactive ingredients in functional foods for the management of IBS-C.
The authors' abstract, as published at the source. Journal of Agricultural and Food Chemistry, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Gastroenterology
GastroenterologyMedicine